Atlas Trials

Phase 3 Trial of Cannabidiol (CBD; GWP42003-P) for Infantile Spasms: Open-label Extension Phase (GWPCARE7)

Clinical trial NCT02954887 · COMPLETED

Trial details

NCT number
NCT02954887
Sponsor
Jazz Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Infantile Spasms
Start date
2017-05-12
Primary completion
2019-06-13
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.